These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21423198)

  • 21. Comparison of tamsulosin vs tamsulosin/sildenafil effectiveness in the treatment of erectile dysfunction in patients affected by type III chronic prostatitis.
    Cantoro U; Catanzariti F; Lacetera V; Quaresima L; Muzzonigro G; Polito M
    Arch Ital Urol Androl; 2013 Sep; 85(3):109-12. PubMed ID: 24085230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erectile dysfunction.
    McMahon CG
    Med J Aust; 2000 Nov; 173(9):492-7. PubMed ID: 11149308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of ED under the "severe distress" criteria in the NHS: a real-life study.
    Mohee A; Bretsztajn L; Storey A; Eardley I
    J Sex Med; 2014 Apr; 11(4):1056-1062. PubMed ID: 24382018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A systematic review assessing the economic impact of sildenafil citrate (Viagra) in the treatment of erectile dysfunction.
    Martin AL; Huelin R; Wilson D; Foster TS; Mould JF
    J Sex Med; 2013 May; 10(5):1389-400. PubMed ID: 23347555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 6-month, prospective, observational study of PDE5 inhibitor treatment persistence and adherence in Middle Eastern and North African men with erectile dysfunction.
    El-Meliegy A; Rabah D; Al-Mitwalli K; Mostafa T; Hussein T; Istarabadi M; Lei Y; Gurbuz S
    Curr Med Res Opin; 2013 Jun; 29(6):707-17. PubMed ID: 23540436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized open-label trial with a crossover comparison of sexual self-confidence and other treatment outcomes following tadalafil once a day vs. tadalafil or sildenafil on-demand in men with erectile dysfunction.
    Rubio-Aurioles E; Porst H; Kim ED; Montorsi F; Hackett G; Morales AM; Stuckey B; Būttner H; West TM; Huynh NN; Lenero E; Burns P; Kopernicky V
    J Sex Med; 2012 May; 9(5):1418-29. PubMed ID: 22429760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Application of the vacuum erectile device in penile rehabilitation for erectile dysfunction after radical prostatectomy].
    Lin H; Wang G; Wang R
    Zhonghua Nan Ke Xue; 2015 Mar; 21(3):195-9. PubMed ID: 25898548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Evaluation of a Clinical Care Pathway for the Management of Men With Nonorganic Erectile Dysfunction.
    Jenkins LC; Hall M; Deveci S; Guhring P; Parker M; Nelson CJ; Mulhall JP
    J Sex Med; 2019 Oct; 16(10):1541-1546. PubMed ID: 31444103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal strategy for penile rehabilitation after robot-assisted radical prostatectomy based on preoperative erectile function.
    Basal S; Wambi C; Acikel C; Gupta M; Badani K
    BJU Int; 2013 Apr; 111(4):658-65. PubMed ID: 23186312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erectile dysfunction diagnosis and treatment as a means to improve medication adherence and optimize comorbidity management.
    Scranton RE; Goldstein I; Stecher VJ
    J Sex Med; 2013 Feb; 10(2):551-61. PubMed ID: 23153075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement in quality of sexual life in female partners of men with erectile dysfunction treated with sildenafil citrate: findings of the Index of Sexual Life (ISL) in a couple study.
    Chevret-Méasson M; Lavallée E; Troy S; Arnould B; Oudin S; Cuzin B
    J Sex Med; 2009 Mar; 6(3):761-9. PubMed ID: 19143916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a progressive treatment program for erectile dysfunction in patients with diabetes mellitus.
    Israilov S; Shmuely J; Niv E; Engelstein D; Livne P; Boniel J
    Int J Impot Res; 2005; 17(5):431-6. PubMed ID: 15889124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on the Safety of Phosphodiesterase Type 5 Inhibitors for the Treatment of Erectile Dysfunction.
    Yafi FA; Sharlip ID; Becher EF
    Sex Med Rev; 2018 Apr; 6(2):242-252. PubMed ID: 28923561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of phosphodiesterase type 5 inhibitors for lower urinary tract symptoms.
    Miller MS
    Ann Pharmacother; 2013 Feb; 47(2):278-83. PubMed ID: 23386068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alprostadil for the treatment of impotence.
    Hanchanale V; Eardley I
    Expert Opin Pharmacother; 2014 Feb; 15(3):421-8. PubMed ID: 24369066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PDE5 inhibitor treatment persistence and adherence in Brazilian men: post-hoc analyses from a 6-month, prospective, observational study.
    Cairoli C; Reyes LA; Henneges C; Sorsaburu S
    Int Braz J Urol; 2014; 40(3):390-9. PubMed ID: 25010306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sildenafil and alprostadil in the combined drug therapy of erectile dysfunction].
    Mazo EB; Dmitriev DG; Gamidov SI; Ovchinnikov RI
    Urologiia; 2002; (3):39-43. PubMed ID: 12180059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraurethral alprostadil for erectile dysfunction: a review of the literature.
    Costa P; Potempa AJ
    Drugs; 2012 Dec; 72(17):2243-54. PubMed ID: 23170913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring the association between erectile rigidity and treatment adherence with sildenafil.
    Mazzola CR; Deveci S; Teloken P; Mulhall JP
    J Sex Med; 2013 Jul; 10(7):1861-6. PubMed ID: 23253943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cumulative response curves to enhance interpretation of treatment differences on the Self-Esteem And Relationship questionnaire for men with erectile dysfunction.
    Cappelleri JC; Zou KH; Bushmakin AG; Carlsson MO; Symonds T
    BJU Int; 2013 Mar; 111(3 Pt B):E115-20. PubMed ID: 23017067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.